A22S (p.Ala22Ser) variant of BTD (Biotinidase)

A22S (p.Ala22Ser) in BTD (Biotinidase) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes population frequency data and structural context.

A22S (p.Ala22Ser) variant details